Biology Reference
In-Depth Information
95. Yoo JW, Kim S, Lee DK (2008) Competition potency of siRNA is specified by the 5¢ -half
sequence of the guide strand. Biochem Biophys Res Commun 367:78-83
96. Koller E, Propp S, Murray H, Lima W, Bhat B, Prakash TP, Allerson CR, Swayze EE,
Marcusson EG, Dean NM (2006) Competition for RISC binding predicts in vitro potency of
siRNA. Nucleic Acids Res 34:4467-4476
97. Ladunga I (2007) More complete gene silencing by fewer siRNAs: transparent optimized
design and biophysical signature. Nucleic Acids Res 35:433-440
98. Huesken D, Lange J, Mickanin C, Weiler J, Asselbergs F, Warner J, Meloon B, Engel S,
Rosenberg A, Cohen D et al (2005) Design of a genome-wide siRNA library using an artificial
neural network. Nat Biotechnol 23:995-1001
99. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A (2004) Rational
siRNA design for RNA interference. Nat Biotechnol 22:326-330
100. Shabalina SA, Spiridonov AN, Ogurtsov AY (2006) Computational models with thermody-
namic and composition features improve siRNA design. BMC Bioinforma 7:65
101. Jagla B, Aulner N, Kelly PD, Song D, Volchuk A, Zatorski A, Shum D, Mayer T, De Angelis
DA, Ouerfelli O et al (2005) Sequence characteristics of functional siRNAs. RNA
11:864-872
102. Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, Ueda R, Saigo K
(2004) Guidelines for the selection of highly effective siRNA sequences for mammalian and
chick RNA interference. Nucleic Acids Res 32:936-948
103. Li W, Cha L (2007) Predicting siRNA efficiency. Cell Mol Life Sci 64:1785-1792
104. Holen T (2005) Mechanisms of RNAi: mRNA cleavage fragments may indicate stalled RISC.
J RNAi Gene Silencing 1:21-25
105. Brown KM, Chu CY, Rana TM (2005) Target accessibility dictates the potency of human
RISC. Nat Struct Mol Biol 12:469-470
106. Schubert S, Grunweller A, Erdmann VA, Kurreck J (2005) Local RNA target structure
influences siRNA efficacy: systematic analysis of intentionally designed binding regions.
J Mol Biol 348:883-893
107. Overhoff M, Alken M, Far RK, Lemaitre M, Lebleu B, Sczakiel G, Robbins I (2005) Local
RNA target structure influences siRNA efficacy: a systematic global analysis. J Mol Biol
348:871-881
108. Tafer H, Ameres SL, Obernosterer G, Gebeshuber CA, Schroeder R, Martinez J, Hofacker IL
(2008) The impact of target site accessibility on the design of effective siRNAs. Nat
Biotechnol 26:578-583
109. Shao Y, Chan CY, Maliyekkel A, Lawrence CE, Roninson IB, Ding Y (2007) Effect of target
secondary structure on RNAi efficiency. RNA 13:1631-1640
110. Kretschmer-Kazemi Far R, Sczakiel G (2003) The activity of siRNA in mammalian cells is
related to structural target accessibility: a comparison with antisense oligonucleotides.
Nucleic Acids Res 31:4417-4424
111. Yuan B, Latek R, Hossbach M, Tuschl T, Lewitter F (2004) siRNA Selection Server: an auto-
mated siRNA oligonucleotide prediction server. Nucleic Acids Res 32:W130-W134
112. Bramsen JB, Laursen MB, Nielsen AF, Hansen TB, Bus C, Langkjær N, Babu BR, Højland T,
Abramov M, Van Aerschot A et al (2009) A large-scale chemical modification screen identifies
design rules to generate siRNAs with high activity, high stability and low toxicity. Nucleic
Acids Res 37:2867-2881
113. Dowler T, Bergeron D, Tedeschi AL, Paquet L, Ferrari N, Damha MJ (2006) Improvements
in siRNA properties mediated by 2¢ -deoxy-2 ¢ - fl uoro-beta-D-arabinonucleic acid (FANA).
Nucleic Acids Res 34:1669-1675
114. Fisher M, Abramov M, Van Aerschot A, Rozenski J, Dixit V, Juliano RL, Herdewijn P (2009)
Biological effects of hexitol and altritol-modified siRNAs targeting B-Raf. Eur J Pharmacol
606:38-44
115. Watts JK, Choubdar N, Sadalapure K, Robert F, Wahba AS, Pelletier J, Pinto BM, Damha MJ
(2007) 2¢ - fl uoro-4 ¢-thioarabino-modified oligonucleotides: conformational switches linked
to siRNA activity. Nucleic Acids Res 35:1441-1451
Search WWH ::
Custom Search